Skip to main content

Table 1 The incident cases and ASIR in 1990 and 2017 and its temporal trends

From: Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study

 

1990

2017

1990–2017

Incident cases

No. *102 (95% UI)

ASIR per 100,000

No. (95% UI)

Incident cases

No. *102 (95% UI)

ASIR per 100,000

No. (95% UI)

EAPC

No. (95% CI)

Overall

729.37 (558.01–793.7)

1.43 (1.1–1.56)

1011.33 (879.68–1187.46)

1.29 (1.12–1.51)

− 0.51 (from − 0.57 to − 0.45)

Sex

 Female

287.61 (212.52–321.94)

1.1 (0.82–1.23)

403.81 (344.46–483.68)

1.03 (0.87–1.23)

-0.4 (from − 0.46 to − 0.33)

 Male

441.76 (321.52–492.58)

1.78 (1.31–2)

607.51 (504.7–748.82)

1.56 (1.29–1.91)

− 0.59 (from − 0.65 to − 0.52)

Socio-demographic index

 High SDI

272.62 (205.49–293.66)

2.57 (1.94–2.77)

349.61 (319.69–464.2)

2.82 (2.56–3.82)

0.19 (0.02–0.36)

 High-middle SDI

159.29 (106.83–191.53)

1.43 (0.96–1.71)

266.55 (206.21–292.54)

1.79 (1.39–1.97)

0.84 (0.6–1.08)

 Middle SDI

106.75 (74.85–122.02)

0.79 (0.56–0.9)

165.29 (135.05–194.99)

0.76 (0.62–0.89)

− 0.31 (− 0.66–0.04)

 Low-middle SDI

113.41 (84.68–131.35)

1.28 (1–1.51)

151.78 (122.97–183.12)

0.95 (0.78–1.15)

− 1.22 (from − 1.27 to − 1.16)

 Low SDI

75.32 (54.46–90.43)

1.34 (1–1.64)

74.47 (62.97–101.86)

0.7 (0.6–0.95)

− 2.58 (from − 2.66 to − 2.49)

Region

 Andean Latin America

2.27 (1.94–2.76)

0.74 (0.63–0.87)

3.23 (2.71–4.01)

0.55 (0.46–0.67)

− 0.96 (from − 1.08 to − 0.83)

 Australasia

5.14 (3.82–5.97)

2.38 (1.76–2.78)

9.83 (7.85–11.79)

3.26 (2.6–3.92)

1.17 (0.94–1.4)

 Caribbean

1.95 (1.65–2.55)

0.6 (0.51–0.79)

5.67 (2.96–7.07)

1.16 (0.61–1.45)

2.61 (1.95–3.27)

 Central Asia

6.44 (5.07–7.57)

1.01 (0.8–1.19)

9.81 (8.15–11.44)

1.07 (0.89–1.24)

0.02 (− 0.14–0.18)

 Central Europe

30.17 (23.4–33.29)

2.32 (1.8–2.57)

33.02 (29.14–40.17)

2.88 (2.52–3.51)

0.78 (0.73–0.83)

 Central Latin America

12.51 (10.11–14.54)

0.98 (0.8–1.13)

22.26 (18.82–27.79)

0.88 (0.75–1.1)

− 0.47 (from − 0.66 to − 0.29)

 Central Sub-Saharan Africa

2.78 (2.07–3.84)

0.73 (0.57–0.98)

4.39 (3.51–5.88)

0.54 (0.42–0.75)

− 1.17 (from − 1.26 to − 1.08)

 East Asia

101.65 (55.81–126.45)

0.88 (0.48–1.09)

190.18 (135.5–216.38)

1.18 (0.86–1.34)

0.92 (0.32–1.52)

 Eastern Europe

75.89 (47.6–96.16)

3.31 (2.03–4.25)

84.95 (74.1–107.26)

3.99 (3.43–5.19)

0.77 (0.53–1.01)

 Eastern Sub-Saharan Africa

24.82 (18.06–31.49)

1.64 (1.25–2.09)

32.12 (23.46–44.47)

1.04 (0.77–1.41)

− 1.94 (from − 2.08 to − 1.8)

 High-income Asia Pacific

7.59 (6.61–9.95)

0.4 (0.35–0.52)

19.12 (13.33–21.99)

0.86 (0.61–1)

3.71 (3.38–4.05)

 High-income North America

104 (76.35–114.3)

3.37 (2.48–3.72)

124.45 (105.69–181.54)

3.23 (2.69–4.84)

− 0.66 (from − 0.98 to − 0.34)

 North Africa and Middle East

35.99 (28.58–44.4)

1.32 (1.08–1.69)

84.81 (59.75–97.89)

1.45 (1.03–1.65)

0.58 (0.36–0.8)

 Oceania

0.3 (0.24–0.38)

0.61 (0.49–0.78)

0.56 (0.39–0.7)

0.54 (0.38–0.68)

− 0.24 (from − 0.36 to − 0.12)

 South Asia

110.08 (79.04–128.65)

1.16 (0.85–1.34)

115.1 (96.77–147.09)

0.68 (0.57–0.87)

− 2.1 (from − 2.18 to − 2.02)

 Southeast Asia

28.26 (22.17–33.2)

0.75 (0.59–0.9)

34.96 (29.01–43.18)

0.53 (0.44–0.65)

− 1.39 (from − 1.46 to − 1.32)

 Southern Latin America

4.66 (4.06–5.94)

0.96 (0.84–1.22)

6.81 (5.67–9.51)

0.95 (0.79–1.33)

− 0.16 (− 0.37–0.05)

 Southern Sub-Saharan Africa

1.75 (1.34–2.03)

0.43 (0.34–0.52)

2.81 (1.96–3.26)

0.4 (0.28–0.46)

− 0.18 (− 0.83–0.48)

 Tropical Latin America

9.6 (8.18–11.77)

0.75 (0.63–0.9)

15.1 (12.48–18.39)

0.65 (0.54–0.79)

− 0.38 (from − 0.47 to − 0.3)

 Western Europe

134.79 (103.14–149.57)

3.14 (2.39–3.51)

167.97 (149–227.28)

3.58 (3.18–4.96)

0.53 (0.38–0.68)

 Western Sub-Saharan Africa

28.72 (18.39–39.7)

1.79 (1.28–2.36)

44.19 (30.78–60.15)

1.24 (0.91–1.69)

− 1.63 (from − 1.76 to − 1.51)

  1. ASIR age-standardized incidence rate